← Back to patent-cliff list
CAS 105601-20-5
3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamateN-Ethyl-N-methylcarbamic acid 3-[1-(N,N-dimethylamino)ethyl]phenyl ester
Codes: RIVAT-003, (V)145089-1-a
Application context (from source-drug indications)
Alzheimer's diseaseRivastigmine TartrateDementiaRivastigmine TartrateParkinson's diseaseRivastigmine Tartrate抗胆碱能综合征Rivastigmine Tartrate神经行为学表现Rivastigmine TartrateCognitive impairmentRivastigmine Tartrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Rivastigmine Tartrate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-(1-(dimethylamino)ethyl)phenol→diethylcarbamic chloride→3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate
1-(3-Hydroxyphenyl)ethanone→3-(1-Aminoethyl)phenol→3-[1-(Dimethylamino)ethyl]phenol→N-Ethyl-N-methylcarbamic chloride→N-Ethyl-N-methylcarbamic acid 3-[1-(N,N-dimethylamino)ethyl]phenyl ester→Formic acid N-methylmethanamine→1-[(1H-Imidazol-1-yl)carbonyl]1H-imidazole→N-Ethyl-N-methylamine→(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.